Found: 1
Select item for more details and to access through your institution.
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 748, doi. 10.1007/s10637-019-00805-4
- By:
- Publication type:
- Article